维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="ERESHEFSKY L"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Pharmacokinetic profile and clinical efficacy of long-acting risperidone显示文摘	ERESHEFSKY L MANNAERT E	2005	Drugs R D2005，6，3：	1
2	Pharmacokinetics and drug inteeration: update for new antipsychotics 显示文摘	Ereshefsky L	1996	J Clin Psychiatry1996，57，11：	1
3	Drug-drug interactions involving antidepressants:focus on venlafaxine显示文摘	Ereshefsky L	1996	Journal of clinical Psychopharmacology1996，16，2：	1
4	Pharmacokinetics and drug interation:update for new antipsychotics显示文摘	Ereshefsky L	1996	J Clin Psychiatry1996，57，：	1
5	Pharmacobogical profile of risperidone显示文摘	Ereshefsky L Lacombes	1993	Can J Psychiatry1993，38，：	1
6	A multi-center study to evaluate the pharmacokinetics and clinical interactions between alprazolam and imipramine显示文摘	Antal EJ Grasel TH Ereshefsky L	1991	J Pharmacokinet Biopharm1991，19，3：	1
7	Drug - drug interactions involving antidepressants: focus on venlafaxine 显示文摘	Ereshefsky L	1996	J Clin Psychopharmacol1996，162，：	1
8	Pharmacokinetics and drug interactions up-date for new antipsychotics显示文摘	Ereshefsky L	1996	J Clin Psychiatry1996，57，11：	1
9	Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmaeodynamics 显示文摘	ERESHEFSKY L MASCARENAS C A	2003	J Clin Psychiatry2003，64，16：	1
10	Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics 显示文摘	ERESHEFSKY L MASCARENAS CA	2003	J Clin Psychiatry2003，64，16：	1
11	Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic 显示文摘	Ereshefsky L	1999	J Clin Psychiatry1999，60，10：	1
12	Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics显示文摘	Ereshefsky L Mascarenasca A	2003	Clin Psychiatry2003，64，16：	1
13	Risperidone clinical efficacy:role of the metabolite 9-OH-risperidone显示文摘	Anderson C True J Ereshefsky L	1994	Psychopharmacol Bull1994，30，1：	1
14	Phamacological profile of risperidone显示文摘	Ereshefsky L	1993	Can J Psycarry1993，38，3：	1
15	Pathophysiologic basis for schizophrenia and the efficacy of antipsychotics显示文摘	Ereshefsky L Tram-Johnson TK Watanabe MD	1990	Clin Pharmacy1990，9，3：	1
16	CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6显示文摘	Lain YW Gaedigk A Ereshefsky L	2002	Pharmacotherapy2002，22，8：	1
17	Lurasidone drug-drug interaction studies: a comprehensive review显示文摘	CHIU YY ERESHEFSKY L PRESKORN SH	2014	Drug Metab Drug Interact2014，29，3：	1
18	Pathophysiologic basis for schizophrenia and the efficacy of antipsychotics显示文摘	ERESHEFSKY L TRAN-JOHNSON T K WATANABE M D	1990	Clin Pharm1990，9，9：	1
19	Drug-drug interactions onvolving antide-pressants:focus on venlafaxine显示文摘	ERESHEFSKY L	1996	J Clin Psych1996，16，2：	1
20	Pharmacologic and pharmacokinetic consideration in choosing an antipsychotic显示文摘	ERESHEFSKY L	1999	J Clin Psychiatry1999，6010，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示